National Center for Women & Information Technology Receives Presidential Award for Excellence

On June 25, 2018, the White House announced the National Center for Women & Information Technology (NCWIT) Aspirations in Computing program as one of 14 organizations to receive the Presidential Award for Excellence in Science, Mathematics and Engineering Mentoring (PAESMEM) — the highest honor bestowed upon mentors who work to expand science, technology, engineering, and mathematics (STEM) talent.

Drug Used to Treat Breast Cancer May Also Save Lives of Rare Uterine Cancer Patients

Adding the monoclonal antibody drug trastuzumab—already used to treat certain breast cancers—to the chemotherapy regimen of women with a rare form of uterine cancer lengthens the amount of time their tumors are kept from growing, according to Johns Hopkins Medicine researchers conducting a small phase II trial of the regimen, testing its safety and value.

Mary Thistle Appointed to Board of Homology Medicines

NEW YORK, March 20, 2018 (GLOBE NEWSWIRE) — Women In Bio (WIB), an organization of professionals committed to promoting careers, leadership, and entrepreneurship of women in the life sciences, is pleased to announce the placement of a alumnae of its Boardroom Ready program to the Board of Directors of Homology Medicines, Inc., a genetics medicine company. Launched in 2016, Boardroom Ready is Executive Women In Bio’s exclusive executive development platform, designed to fuel women’s participation on corporate boards in the life sciences.

New Technique May Preserve Fertility in Young Girls Undergoing Chemotherapy

Belgian researchers have found that a triple-wash technique is effective for cleansing antral follicles (egg-containing cells) isolated from ovarian tissue contaminated with malignant cells, while maintaining the follicles’ viability. This is an essential step in developing a process to preserve fertility for young girls who must undergo chemotherapy to treat childhood cancer, particularly leukemia.